BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«In Vitro Technologies

Below is an extended In Vitro Technologies research listing. Click here to return to the In Vitro Technologies main Biocorporate entry.

Recent Publications by In Vitro Technologies:

Receptor mechanisms: Principles of agonism.
This conference was the first of a series of biannual meetings covering...
10th May, 2008
In Vitro Technologies Inc, 1450 South Rolling Road, Baltimore, MD 21227, IDrugs. 1998 Oct;1(6):657-9.
Microsomes and drug oxidations.
The microsome and drug oxidation symposium series started 20 years ago as...
10th May, 2008
In Vitro Technologies Inc, 1450 South Rolling Road, Baltimore, MD 21227, IDrugs. 1998 Oct;1(6):635-8.
Preclinical evaluation of drug-drug interactions using human in vitro experimental systems.
The microsome and drug oxidation symposium series started 20 years ago as...
10th May, 2008
In Vitro Technologies Inc, 1450 South Rolling Rd, Baltimore MD 21227 USA. IDrugs. 1998 Jul;1(3):311-4.
The effect of EGF and the comitogen, norepinephrine, on the proliferative responses of fresh and cryopreserved rat and mouse hepatocytes.
The effect of cryopreservation on the proliferative response of fresh and...
17th January, 2007
In Vitro Technologies Inc. 1450 South Rolling Road, Baltimore, MD 21227, Cryobiology. 2006 Oct;53(2):182-93. Epub 2006 Aug 2.
DOI Direct Link
Cryopreserved rat, dog and monkey hepatocytes: measurement of drug metabolizing enzymes in suspensions and cultures.
Metabolism in fresh and cryopreserved (CP) rat, dog and monkey hepatocyte...
5th January, 2005
In Vitro Technologies Inc., 1450 South Rolling Road, Baltimore, MD 21227, Hum Exp Toxicol. 2004 Jun;23(6):307-16.
Phase I and II enzyme characterization of two sources of HepG2 cell lines.
1: The metabolism by HepG2 cell from two sources (M1, M2) of 12 substrates...
13th November, 2004
In Vitro Technologies, 1450 South Rolling Road, Baltimore, MD 21227, USA. Xenobiotica. 2004 Mar;34(3):243-56.
DOI Direct Link
Induction of morphological and biochemical apoptosis following prolonged mitotic blockage by halichondrin B macrocyclic ketone analog E7389.
E7389, a macrocyclic ketone analog of the marine natural product...
2nd October, 2004
Department of Candidate Assessment and In Vitro Technologies, Eisai Cancer Res. 2004 Aug 15;64(16):5760-6.
DOI Direct Link
Early ADME/Tox studies and in silico screening.
We report here our studies on troglitazone and rosiglitazone cytotoxicity...
25th February, 2003
In Vitro Technologies, Baltimore MD, USA. Drug Discov Today. 2002 Jan 1;7(1):25-7.
Identification of glutathione conjugates of troglitazone in human hepatocytes.
Troglitazone (TGZ) is an orally active antihyperglycemic agent used in the...
20th December, 2002
In Vitro Technologies, Inc., 1450 South Rolling Road, Baltimore, MD 21202, Chem Biol Interact. 2002 Nov 10;142(1-2):83-97.
Correlation between troglitazone cytotoxicity and drug metabolic enzyme activities in cryopreserved human hepatocytes.
Troglitazone (TRO) was developed for the treatment of type II diabetes. It...
20th December, 2002
In Vitro Technologies, Inc., 1450 South Rolling Road, Baltimore, MD 21227, Chem Biol Interact. 2002 Nov 10;142(1-2):73-82.
Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donors.
We report here our studies on troglitazone and rosiglitazone cytotoxicity...
20th December, 2002
In Vitro Technologies, Inc., 1450 South Rolling Road, Baltimore, MD 21227, Chem Biol Interact. 2002 Nov 10;142(1-2):57-71.
Screening for human ADME/Tox drug properties in drug discovery.
There is no doubt that ADME/Tox drug properties, absorption, distribution,...
27th March, 2001
In Vitro Technologies, 1450 S. Rolling Rd, 21227, Baltimore, MD, USA Drug Discov Today. 2001 Apr 1;6(7):357-366.

«In Vitro Technologies

This page contained an extended In Vitro Technologies research listing. Click here to return to the In Vitro Technologies main Biocorporate entry.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.